selected scholarly activity
-
conferences
- Effects of ALK Tyrosine Kinase Inhibitors in the Treatment of Metastatic NSCLC: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology. S1089-S1090. 2021
- P45.10 Effects of ALK Tyrosine Kinase Inhibitors in the Treatment of Metastatic NSCLC: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology. S1089-S1090. 2021
- Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology. S506-S507. 2021
- P1.01-55 Updated Analysis of Outcomes by Histology vs Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. S379-S380. 2019
-
journal articles
- Molecular Testing in Non–Small-Cell Lung Cancer: A Call to Action. JCO Oncology Practice. 20:7-9. 2024
- Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease. Current Oncology. 30:9514-9529. 2023
- Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis. Current Oncology. 29:9046-9065. 2022
- Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib. Hepatology. 74:1705-1707. 2021
- P48.18 Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology. 16:S506-S507. 2021
- Evaluation of a novel strategy to implement exercise evidence into clinical practice in breast cancer care: protocol for the NEXT-BRCA randomised controlled trial. BMJ Open Sport and Exercise Medicine. 6:e000922-e000922. 2020
- Learning Health System for Breast Cancer: Pilot Project Experience. JCO clinical cancer informatics. 3:1-11. 2019
- Use of alkylating chemotherapy in high-grade neuroendocrine tumours: Evaluation of real-world data.. Journal of Clinical Oncology. 34:78-78. 2016
- Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: Therapeutic implications for Alzheimer's disease. Neuroscience Letters. 576:84-87. 2014
- Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain. International Journal of Neuropsychopharmacology. 15:1343-1350. 2012